1. Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrate

   Brekelmans, M. P. A., Abdoellakhan, R. A., Scheres, L. J. J., Biedermann, J. S., Hutten, B. A., Meijer, K., ten Cate, H., Huisman, M., Kruip, M. J. H. A., Middeldorp, S. & Coppens, M., Jan-2018, In : Research and practice in thrombosis and haemostasis. 2, 1, p. 77-84 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3)

   Abdoellakhan, R. A., Khorsand, N., Van Hest, R. M., Veeger, N., Ter Avest, E., Ypma, P. F., Faber, L. M. & Meijer, K., 14-Mar-2018, In : BMJ Open. 8, 3, 7 p., e020764.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis

   Abdoellakhan, R. A., Miah, I. P., Khorsand, N., Meijer, K. & Jellema, K., Feb-2017, In : Neurocritical care. 26, 1, p. 64-69 6 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients

   van Maarseveen, E., van Buul-Gast, M-C., Abdoellakhan, R., Gelinck, L., Neef, C. & Touw, D., Sep-2014, In : Journal of Antimicrobial Chemotherapy. 69, 9, p. 2581-2583 3 p., dku175.

   Research output: Contribution to journal › Letter › Academic › peer-review

View all (4) »